Low-risk profile for malignant ventricular arrhythmias and sudden cardiac death after surgical ventricular

Massimo Baravelli1, Paolo Cattaneo, Andrea Rossi

  • 1Department of Cardiology and Intensive Cardiac Rehabilitation, Multimedica Holding, Castellanza, Varese, Italy. massimo.baravelli@virgilio.it

Insights

Surgical ventricular reconstruction (SVR) added to coronary artery bypass grafting (CABG) shows a low incidence of sudden cardiac death and ventricular arrhythmias. Preoperative left ventricular end-systolic volume index and postoperative pulmonary artery systolic pressure predict these arrhythmic events.

Area of Science:

  • Cardiology
  • Cardiac Surgery

Background:

  • Surgical ventricular reconstruction (SVR) combined with coronary artery bypass grafting (CABG) has shown comparable survival and clinical outcomes to CABG alone.
  • However, the impact of SVR on the risk of cardiac arrhythmias in these patients remains unclear.

Purpose of the Study:

  • To determine the incidence of sudden cardiac death (SCD) and sustained ventricular tachycardia/ventricular fibrillation (VT/VF) after SVR + CABG.
  • To identify clinical and echocardiographic predictors of in-hospital and long-term arrhythmic events.

Main Methods:

  • Retrospective evaluation of 65 patients who underwent SVR + CABG.
  • Analysis included pre- and postoperative clinical data, echocardiography, and electrocardiogram Holter monitoring.

Main Results:

  • At 3 years, the rate of freedom from SCD was 98%, and freedom from any arrhythmic event was 88%.
  • Independent predictors for arrhythmic events were a preoperative left ventricular end-systolic volume index (LVESVI) > 102 mL/m² and postoperative pulmonary artery systolic pressure (PASP) > 27 mmHg.

Conclusions:

  • SVR added to CABG is associated with a low incidence of arrhythmic events, even in high-risk patients.
  • Preoperative LVESVI and postoperative PASP are valuable predictors of arrhythmic events in this population.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...